1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis Ixazomib (NINLARO®) capsules / Matching placebo capsules - Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 1 | Recruiting | Queen Mary University of London | 72 | 2020-06-15 | 2026-09-08 |
Multiple Sclerosis, Chronic Progressive (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Chronic Disease (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Multiple Sclerosis (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Queen Mary University of London (1)
United Kingdom (1)
2018 (1)